Adam is a Precision Imaging Beacon Early Career Research Fellow. His research largely focuses on the development of methodology for MR spectroscopy (MRS) with the aim to improve its clinical value. At 7 T, MRS is emerging as a promising tool for neurochemical measurement in diseases such as psychiatric illness. Adam’s current research interests are therefore to develop parallel transmit methods for MRS to overcome challenges associated with ultra-high field. This will result in improved robustness and coverage of MRS across the brain for elucidation of sensitive neurochemical changes in disease.
During his PhD, Adam worked on acquisition techniques to improve the in vivo detection of 2-hydroxyglutarate, a key mutational biomarker present in the majority of gliomas, at 3 T and 7 T. More recently, as a postdoctoral researcher at Johns Hopkins in Baltimore, Adam developed a standardized acquisition protocol across several vendor platforms in order to reduce variability in metabolite measurements for multi-site clinical studies.